|
FAM83D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.357570E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.42669999999112E-05 |
| Normal-vs-Stage2 |
9.92690000000129E-05 |
| Normal-vs-Stage3 |
4.164400E-01 |
| Normal-vs-Stage4 |
2.907800E-01 |
| Stage1-vs-Stage2 |
6.540800E-01 |
| Stage1-vs-Stage3 |
6.225500E-04 |
| Stage1-vs-Stage4 |
1.007630E-02 |
| Stage2-vs-Stage3 |
1.076140E-03 |
| Stage2-vs-Stage4 |
6.898400E-03 |
| Stage3-vs-Stage4 |
8.310200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.14579999999742E-05 |
| Normal-vs-AfricanAmerican |
6.40429999999581E-05 |
| Normal-vs-Asian |
7.948200E-01 |
| Caucasian-vs-AfricanAmerican |
1.929400E-01 |
| Caucasian-vs-Asian |
3.072400E-01 |
| AfricanAmerican-vs-Asian |
2.596400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.011770E-04 |
| Normal-vs-Female |
1.038780E-01 |
| Male-vs-Female |
1.608250E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.955000E-04 |
| Normal-vs-Extreme_Weight |
1.88288999999342E-05 |
| Normal-vs-Obese |
3.019000E-03 |
| Normal-vs-Extreme_Obese |
9.96909999995133E-07 |
| Normal_Weight-vs-Extreme_Weight |
7.720000E-02 |
| Normal_Weight-vs-Obese |
7.713200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.596500E-03 |
| Extreme_Weight-vs-Obese |
3.730000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.266000E-02 |
| Obese-vs-Extreme_Obese |
1.857720E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.819200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.28879999999832E-05 |
| Normal-vs-Age(61-80Yrs) |
1.515519999995E-05 |
| Normal-vs-Age(81-100Yrs) |
1.640870E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.114500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.434200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.227600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.090000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.280600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.116800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.38270000002738E-06 |
| Normal-VS-Type2 PRCC |
2.278300E-02 |
| Normal-VS-KIRP CIMP |
6.827500E-02 |
| Normal-VS-Unclassified PRCC |
7.032500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.956900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.223600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.298100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.848900E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.415810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.362330E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.483100E-03 |
| Normal-vs-N1 |
1.501000E-01 |
| Normal-vs-N2 |
9.151600E-01 |
| N0-vs-N1 |
3.024700E-03 |
| N0-vs-N2 |
1.921820E-01 |
| N1-vs-N2 |
4.767000E-01 |
|
|
